Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
    • PYQ Mastery Program
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
      • PYQ Mastery Program
    • Portal Login
    Drugmaler Hetero is first generic to get WHO pre-qualification approval
    December 27, 2022

        Drugmaler Hetero is first generic to get WHO pre-qualification approval Subject :Science and Technology Context: Drugmaker Hetero said it has received World Health Organization (WHO) prequalification approval for its generic version of Pfizer’s Covid-19 oral antiviral treatment candidate nirmatrelvir. Hetero’s combi-pack Nirmacom will contain nirmatrelvir 150 mg (2 tablets) and ritonavir 100mg (1 […]

    Posted in: DPN Topics ,
    Tags: Drugmaler Hetero is first generic to get WHO pre-qualification approval , Science and tech ,

    Recent Posts

    • Daily Prelims Notes 23 March 2025 March 23, 2025
    • Challenges in Uploading Voting Data March 23, 2025
    • Fertilizers Committee Warns Against Under-Funding of Nutrient Subsidy Schemes March 23, 2025
    • Tavasya: The Fourth Krivak-Class Stealth Frigate Launched March 23, 2025
    • Indo-French Naval Exercise Varuna 2024 March 23, 2025
    • No Mismatch Between Circulating Influenza Strains and Vaccine Strains March 23, 2025
    • South Cascade Glacier March 22, 2025
    • Made-in-India Web Browser March 22, 2025
    • Charting a route for IORA under India’s chairship March 22, 2025
    • Mar-a-Lago Accord and dollar devaluation March 22, 2025
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search